These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18851691)

  • 1. Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease?
    Katsargyris A; Klonaris C; Bastounis E; Theocharis S
    Expert Opin Ther Targets; 2008 Nov; 12(11):1329-46. PubMed ID: 18851691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction.
    Navi A; Patel H; Shaw S; Baker D; Tsui J
    Vascul Pharmacol; 2013 Mar; 58(3):231-9. PubMed ID: 23070056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR signalling and association of TLR polymorphism with cardiovascular diseases.
    Sharma S; Garg I; Ashraf MZ
    Vascul Pharmacol; 2016 Dec; 87():30-37. PubMed ID: 27826031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the toll-system in cardiovascular sciences.
    Földes G; von Haehling S; Jankowska EA; Anker SD
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):57-67. PubMed ID: 19075967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor modulation in cardiovascular disease: a target for intervention?
    Földes G; von Haehling S; Anker SD
    Expert Opin Investig Drugs; 2006 Aug; 15(8):857-71. PubMed ID: 16859390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors as potential therapeutic targets in cardiac dysfunction.
    Hofmann U; Ertl G; Frantz S
    Expert Opin Ther Targets; 2011 Jun; 15(6):753-65. PubMed ID: 21385118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor family in domestic animal species.
    Turin L; Riva F
    Crit Rev Immunol; 2008; 28(6):513-38. PubMed ID: 19265507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
    Hanke ML; Kielian T
    Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of toll-like receptors in cardiovascular diseases.
    Vallejo JG
    Clin Sci (Lond); 2011 Jul; 121(1):1-10. PubMed ID: 21413930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA regulation of Toll-like receptor signaling pathways in teleost fish.
    Zhou Z; Lin Z; Pang X; Shan P; Wang J
    Fish Shellfish Immunol; 2018 Apr; 75():32-40. PubMed ID: 29408644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors as interferon-regulated genes and their role in disease.
    Khoo JJ; Forster S; Mansell A
    J Interferon Cytokine Res; 2011 Jan; 31(1):13-25. PubMed ID: 21198355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting negative regulation of Toll-like receptor signaling.
    Kondo T; Kawai T; Akira S
    Trends Immunol; 2012 Sep; 33(9):449-58. PubMed ID: 22721918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of Toll-like receptors in cutaneous disorders.
    Matin N; Tabatabaie O; Mohammadinejad P; Rezaei N
    Expert Opin Ther Targets; 2015; 19(12):1651-63. PubMed ID: 26189326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the toll-like receptors in sexually transmitted infections.
    Yadav S; Verma V; Singh Dhanda R; Yadav M
    Scand J Immunol; 2021 Jan; 93(1):e12954. PubMed ID: 32762084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and function of toll-like receptors in B lymphocytes].
    Liu HZ; Yang HZ; Hu ZW
    Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.